Innate Pharma S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innate Pharma S.A. with three other
companies in this sector in France:
sales of 74.61 million Euro [US$83.83 million]
(25.45 million Euro [US$28.60 million]
(47.39 million Euro [US$53.25 million]
of which 100%
was Regenerative Medicine).
Innate Pharma S.A. reported sales of 79.89 million Euro (US$89.77 million)
December of 2018.
increase of 144.8%
versus 2017, when the company's sales were 32.63 million Euro.